XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 50 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,476,000 | -44.8% | 602,634 | -8.2% | 0.00% | – |
| Q2 2021 | $2,673,000 | +26.5% | 656,742 | +40.1% | 0.00% | – |
| Q1 2021 | $2,113,000 | -26.7% | 468,662 | -20.0% | 0.00% | – |
| Q4 2020 | $2,882,000 | +144.7% | 585,797 | +194.8% | 0.00% | – |
| Q3 2020 | $1,178,000 | +392.9% | 198,706 | +121.1% | 0.00% | – |
| Q2 2020 | $239,000 | +443.2% | 89,888 | +299.5% | 0.00% | – |
| Q1 2020 | $44,000 | -43.6% | 22,500 | +104.5% | 0.00% | – |
| Q4 2019 | $78,000 | -74.1% | 11,000 | -63.3% | 0.00% | – |
| Q1 2019 | $301,000 | +40.7% | 29,941 | +165.2% | 0.00% | – |
| Q2 2018 | $214,000 | – | 11,290 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|